#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immune-mediated myositis Thromboangiitis obliterans Mitochondrial myopathy Obesity Myelofibrosis Ewing's sarcoma metastatic Craniopharyngioma Mucous membrane pemphigoid Intracranial germ cell tumour Fabry's disease Nodal marginal zone B-cell lymphoma Hyperinsulinism Infective uveitis Hyperadrenocorticism Autoimmune disorder More trials…

    Learn about Rare Diseases

    Pulmonary sarcoidosis – Basic Information Idiopathic pulmonary fibrosis – Diagnostics Burkitt’s lymphoma Haemophilia B without inhibitors – Trials in Disease Antithrombin III deficiency – Diagnostics Acute respiratory distress syndrome – Basic Information Sjogren’s syndrome – Diagnostics Primary immunodeficiency syndrome – Basic Information Ornithine transcarbamoylase deficiency – Treatment Loeys-Dietz syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ecoo18A Df6002 L-Arginine Hydrochloride Fosfomycin Prucalopride Maraviroc Octreotide Hydrochloride AGA2118 Imipenem Anhydrate HUPERZINE A Dexamethasone Phosphate Procarbazine Hydrochloride Zidesamtinib Cdr132L Daratumumab Efavirenz Metformin Embonate Magnesium Sulfate Heptahydrate Atidarsagene Autotemcel Prednisolone Sodium Succinate More therapies…

    Learn about Your Condition

    Adenomyosis Intestinal ischaemia Vertebrobasilar stroke Hypochondroplasia Necrotising myositis Metastatic gastric cancer Post-traumatic stress disorder Plasmablastic lymphoma Nicotine dependence Cystic fibrosis Leiomyosarcoma recurrent Diabetic neuropathy Cervix carcinoma stage I Small fibre neuropathy Drug dependence More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hospital Universitari General De Catalunya

Hospital Universitari General De Catalunya

Carrer Pedro I Pons 1, Sant Cugat Del Valles, 08195, Spain

Want to learn more about this study or check if you can participate? Contact us.

  • Study on BI 764524 for Patients with Moderate to Severe Diabetic Retinopathy

    Not recruiting

    2 1
    Investigated Drugs:
    • Bi 764524
    Germany Hungary Italy Poland Spain

  • Study of Durvalumab, Olaparib, and Fulvestrant for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer with Specific Genetic Alterations

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Hormone receptor positive breast cancer
    Investigated Drugs:
    • Olaparib
    • Goserelin Acetate
    Belgium France Spain

  • Study on the Safety and Tolerability of Exidavnemab in Patients with Mild to Moderate Parkinson’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Multiple system atrophy
    • Parkinson’s disease
    Investigated Drugs:
    • Exidavnemab
    Poland Spain

  • Study on Bepranemab for Patients with Early Alzheimer’s Disease

    Not recruiting

    2 1 1
    Investigated Drugs:
    • 2-(4-(2-[18F]FLUORO-2,2-DIDEUTERO ETHYL)PIPERIDIN-1-YL)BENZO[4,5]IMIDAZO[1,2-A]PYRIMIDINE
    • Bepranemab
    • Florbetaben (18F)
    Belgium France Germany Italy The Netherlands Poland +1
Previous Page
1 … 6 7 8

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!